Bipolar 1 Disorder Terminated Phase 2 Trials for scyllo-inositol (DB03106)

IndicationStatusPhase
DBCOND0020745 (Bipolar 1 Disorder)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01674010Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I DisorderTreatment